1.    Review the pathophysiology and clinical presentation of paclitaxel-associated hypersensitivity reactions (HSR)
2.    Describe the impact of a standardized paclitaxel titration protocol on HSR incidence and severity
3.    Discuss the clinical implications and future directions for optimizing paclitaxel administration
 

Session date: 
06/25/2026 - 8:00am to 9:00am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Gabrielle O. Carreon, PharmD, MS